In 2008, male physicians who were newly trained in New York State made an average of $16,819 more than newly trained female physicians, compared to a $3,600 difference in 1999, according to a study published in the February issue of Health Affairs.
MONDAY, Feb. 21 (HealthDay News) -- In 2008, male physicians who were newly trained in New York State made an average of $16,819 more than newly trained female physicians, compared to a $3,600 difference in 1999, according to a study published in the February issue of Health Affairs.
Anthony T. Lo Sasso, Ph.D., from the University of Illinois at Chicago, and colleagues studied the starting salaries by gender of physicians leaving their residency programs in New York State between 1999 and 2008. They sought to determine whether the gender gap could be explained by specialty choice, work hours, or practice setting.
The researchers found that there was a significant gender gap that could not be explained by any characteristics, including choice of specialty, practice setting, or work hours. They also found that the pay gap trend seemed to be a recent development that has grown with time. They noted that female physicians were entering into formerly male-dominated and traditionally higher paying subspecialties, so the notion that women tend to enter primary care, a lower-paying specialty, was not found to be the case.
"Considering our findings, and in light of the continuing rise in the number of female physicians, policy makers, physician practice groups, and medical training programs should reconsider how they attract providers, how they construct their working arrangements, and how they pay," the authors write.
AbstractFull Text (subscription or payment may be required)
Related Content
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More